Teleflex (TFX) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 10/31/24
First Patient Enrolled in Teleflex's Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)GlobeNewsWire • 10/29/24
TFX Stock to Gain From Launch of New Vascular Access Devices in CanadaZacks Investment Research • 10/28/24
Teleflex launches next-generation Arrow™ VPS Rhythm™ DLX Device and NaviCurve™ Stylet in CanadaGlobeNewsWire • 10/23/24
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)GlobeNewsWire • 10/17/24
Teleflex's Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual MeetingGlobeNewsWire • 09/26/24
Teleflex™ Chooses o9's AI-Powered Platform for End-to-End Integrated Business Planning and Supply Chain ManagementBusiness Wire • 09/25/24
Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewsWire • 08/22/24
Teleflex Announces Publication of a Propensity Matching Review of Retrospective Data Reporting that the Titan SGS™ Stapler Enables Consistent Gastric Pouch Formation with Fewer Variations, Providing Potentially Enhanced Clinical Outcomes and Significant Procedural Efficiency Compared with Traditional Surgical StaplersGlobeNewsWire • 08/21/24